>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
新疆乳腺癌患者外周血中p16基因甲基化的检测意义
作者:李莉1  鲁英1  杨晓燕1  欧江华2  齐新2 
单位:1. 新疆医科大学公共卫生学院 劳动卫生与环境卫生学教研室, 新疆 乌鲁木齐 830011;
2. 新疆医科大学附属肿瘤医院 乳腺外科, 新疆 乌鲁木齐 830011
关键词:乳腺癌 p16基因 甲基化 焦磷酸测序 
分类号:R737.9
出版年·卷·期(页码):2014·33·第六期(691-696)
摘要:

目的: 探讨新疆乳腺癌患者p16基因甲基化的情况.方法: 按照1:1配比的病例对照研究,采用聚合酶链反应(PCR)对54对研究对象外周血中p16基因进行扩增后焦磷酸测序,检测该基因的甲基化情况.结果: 经单因素分析,p16基因各基因位点甲基化程度差异没有统计学意义(P>0.05).根据ER阴性阳性分组,PM00139972CpG-2的甲基化程度差异有统计学意义(P<0.05);根据HER-2阴性阳性分组,PM00139972CpG-4的甲基化程度差异有统计学意义(P<0.05).结论: 对新疆乳腺癌患者p16基因各位点的检测结果表明,其异常甲基化对乳腺癌的预后可能有意义.

Objective: To investigate the methylation of p16 gene in patients of breast cancer in Xinjiang. Methods: 1:1 case-control was adopted and the tumor suppressor gene p16 was amplified by polymerase chain reaction(PCR) in the peripheral blood of 54 pairs of subjects,and followed the pyrosequencing to detect the methylation of the gene. Results: Univariate analysis showed that the difference of methylation degree of each p16 gene was not statistically significant. The degree of methylation difference of PM00139972CpG-2 was statistically significant according to ER-negative-positive group; and the degree of methylation difference of PM00139972CpG-4 was statistically significant according to HER-2-negative-positive group. Conclusion: The abnomal mathylation of each p16 gene in Xinjiang breast cancer patients may be meaningful for the prognosis of breast cancer.

参考文献:

[1] FENG J,HU L H,LU J,et al.Diagnostic value of BRCA1 and p16 gene methylation in sporadic breast cancer[J].CJC,2009,28(4): 1-6.
[2] TANG L C,YIN W J,DI G H,et al.Unfavorable clinic pathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young chinese breast cancer patients[J].Breast Cancer Res Treat,2010,122: 95-104.
[3] 韩璐璐,刘剑仑.调控细胞周期的乳腺癌抑癌基因的研究进展[J].中国癌症防治杂志,2011,4(3): 339-340.
[4] KWONG A,CHEUNG P,CHAN S,et al.Breast cancer in chinese women younger than age 40: are they different from their older counterparts?[J].World J Surg,2008,32: 2554-2561.
[5] HINSHELWOOD R A,MELKI J R,HUSCHTSCHA L I,et al.Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning[J].Hum Mol Genet,2009,16(28): 3098-3109.
[6] VALLIAN S,SEDAGHAT M,NASSIRI I,et al.Methylation status of p16INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer[J].J Cancer Res Clin Oncol,2009,135: 991-996.
[7] ZHAO L,YU Z J,LI Y N,et al.Clinical implications of ERb methylation on sporadic breast cancers in Chinese women[J].Med Oncol,2012,29: 1569-1575.
[8] 张,郑荣生.乳腺癌患者血清中p16基因甲基化状态的研究[J].临床肿瘤学杂志,2010,15(5): 399-402.
[9] MENG H T,PETER G S,JING N,et al.DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer(WEB)Study[J].Breast Cancer Res Treat,2009,114: 559-568.
[10] 曾谷清,康颖,高天舒,等.乳腺癌组织中P16蛋白的表达与细胞增殖的关系[J].中国现代医学杂志,2007,6(17): 650-653.
[11] THOMAS M,JÖRG F,CHELSEE A H.Analysing DNA methylation using bisulphite pyrosequencing[M].USA: Humana Press,2011: 33-53.
[12] SHEN S X,DAHUI Q.Pyrosequencing data analysis software: a useful tool for EGFR,KRAS,and BRAF mutation analysis[J].Diagn Pathol,2012,7: 56.
[13] 魏茂富,杨延莉,刘镜文.P16在乳腺癌及乳腺腺病中的表达及其临床意义[J].临床探讨,2010,48(7): 138-139.
[14] 秦洪真,汪敏,李席如,等.乳腺癌患者CerbB-2表达和组织激素受体、淋巴结转移的关系[J].现代医学,2009,37(5): 336-338.
[15] 蒋文英,桑剑锋,苏磊,等.乳腺癌新辅助化疗疗效及其判断方法[J].现代医学,2011,39(2): 237-240.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 405897 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364